English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Hepatic FTO is dispensable for the regulation of metabolism but counteracts HCC development in vivo

MPS-Authors
/persons/resource/persons226965

Mittenbühler,  Melanie
Obesity and Cancer, Department Jens Brüning, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

/persons/resource/persons147322

Ullrich,  Roland T.
Klinisches PET, Neurologische Abteilung, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

/persons/resource/persons147140

Brüning,  Jens Claus
Brüning – Neuronal Control of Metabolism, Department Brüning, Max Planck Institute for Metabolism Research, Max Planck Society;

/persons/resource/persons147349

Wunderlich,  Frank Thomas
Wunderlich – Obesity and Cancer, Department Brüning, Max Planck Institute for Metabolism Research, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Mittenbühler, M., Saedler, K., Nolte, H., Kern, L., Zhou, J., Qian, S.-B., et al. (2020). Hepatic FTO is dispensable for the regulation of metabolism but counteracts HCC development in vivo. Molecular Metabolism, 42: 101085. doi:10.1016/j.molmet.2020.101085.


Cite as: https://hdl.handle.net/21.11116/0000-0007-43E2-E
Abstract
There is no abstract available